Continuous infusion of high‐dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study

BACKGROUND: Ulinastatin can prevent the perioperative increase in proinflammatory cytokines for lung resection surgery; however, its impact on early clinical outcomes remains unknown. METHODS: The study enrolled 108 non‐small cell lung cancer (NSCLC) patients who were randomly allocated into two gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Leng, Lan, Haidan, Zhou, Qinghua, Tang, Xiao Jun, Zhu, Daxing, Yue, Jianming, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129221/
https://www.ncbi.nlm.nih.gov/pubmed/27766771
http://dx.doi.org/10.1111/1759-7714.12371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129221/
https://www.ncbi.nlm.nih.gov/pubmed/27766771
http://dx.doi.org/10.1111/1759-7714.12371

Ejemplares similares